Japan Results Roundup: Strong Mainstays, Currency Windfall Help Top Line

 
• By Lisa Takagi
  
Major Japanese pharmaceutical firms' Q2 performance was largely supported by their US performance with weak forex rate.
Major Japan pharma firms' Q1 performance supported by global performance, weak yen • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Japan

More from Focus On Asia